DJ Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ shed 4.27% to $1.12 Thursday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.47% to 25,881.95 and Dow Jones Industrial Average falling 0.20% to 52,552.97.
Inovio Pharmaceuticals Inc. closed 62.40% below its 52-week high of $2.98, which the company reached on September 9th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 1.19% to $249.97, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 1.29% to $25.14.
Trading volume (1.1 M) remained 1.5 million below its 50-day average volume of 2.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 16, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 16, 2026 17:23 ET (21:23 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments